XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues $ 68,690 $ 71,831 $ 115,953 $ 189,781
Cost of goods sold 68,198 72,935 114,800 194,184
Gross profit (loss) 492 (1,104) 1,153 (4,403)
Research and development expenses 36 52 115 139
Selling, general and administrative expenses 8,985 6,439 29,480 21,166
Operating loss (8,529) (7,595) (28,442) (25,708)
Interest expense        
Interest rate expense 8,749 5,456 24,126 14,819
Debt related fees and amortization expense 1,433 1,633 4,732 5,199
Accretion and other expenses of Series A preferred units 7,739 2,774 20,188 5,920
Loss (gain) on debt extinguishment 0 49,386 0 49,386
Gain on litigation 0 0 0 (1,400)
Other income (1,853) (2) (2,020) (14,297)
Loss before income taxes (24,597) (66,842) (75,468) (85,335)
Income tax expense (benefit) (55,308) 3 (54,490) 13
Net income (loss) 30,711 (66,845) (20,978) (85,348)
Other comprehensive income (loss)        
Foreign currency translation loss (260) (300) (127) (884)
Comprehensive income (loss) $ 30,451 $ (67,145) $ (21,105) $ (86,232)
Net income (loss) per common share        
Basic (in dollars per share) $ 0.79 $ (1.92) $ (0.56) $ (2.49)
Diluted (in dollars per share) $ 0.73 $ (1.92) $ (0.56) $ (2.49)
Weighted average shares outstanding        
Weighted average shares outstanding—basic (in shares) 38,881 34,769 37,504 34,344
Diluted (in shares) 41,841 34,769 37,504 34,344